Cargando…
Addressing Drug Resistance in Cancer: A Team Medicine Approach
Drug resistance remains one of the major impediments to treating cancer. Although many patients respond well initially, resistance to therapy typically ensues. Several confounding factors appear to contribute to this challenge. Here, we first discuss some of the challenges associated with drug resis...
Autores principales: | Kulkarni, Prakash, Mohanty, Atish, Bhattacharya, Supriyo, Singhal, Sharad, Guo, Linlin, Ramisetty, Sravani, Mirzapoiazova, Tamara, Mambetsariev, Bolot, Mittan, Sandeep, Malhotra, Jyoti, Gupta, Naveen, Kim, Pauline, Babikian, Razmig, Rajurkar, Swapnil, Subbiah, Shanmuga, Tan, Tingting, Nguyen, Danny, Merla, Amartej, Kollimuttathuillam, Sudarsan V., Phillips, Tanyanika, Baik, Peter, Tan, Bradford, Vashi, Pankaj, Shrestha, Sagun, Leach, Benjamin, Garg, Ruchi, Rich, Patricia L., Stewart, F. Marc, Pisick, Evan, Salgia, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572909/ https://www.ncbi.nlm.nih.gov/pubmed/36233569 http://dx.doi.org/10.3390/jcm11195701 |
Ejemplares similares
-
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
por: Ramisetty, Sravani, et al.
Publicado: (2023) -
A Nexus between Genetic and Non-Genetic Mechanisms Guides KRAS Inhibitor Resistance in Lung Cancer
por: Kulkarni, Prakash, et al.
Publicado: (2023) -
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine
por: Sattler, Martin, et al.
Publicado: (2023) -
Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report
por: Fricke, Jeremy, et al.
Publicado: (2020) -
Recent Advancement in Breast Cancer Research: Insights from Model Organisms—Mouse Models to Zebrafish
por: Singhal, Sharad S., et al.
Publicado: (2023)